Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis.

Jesper Rømhild DavidsenLars Christian LundChristian Borbjerg LaursenJesper HallasDaniel Pilsgaard Henriksen

Published in: ERJ open research (2020)

Among IPF patients, an increased drug use was observed for diagnoses with symptoms overlapping those of IPF, particularly this was observed during the last 6 months before an IPF diagnosis. This emphasises the need for an increased IPF awareness.

Keyphrases

idiopathic pulmonary fibrosis
interstitial lung disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
rheumatoid arthritis
patient reported outcomes
smoking cessation
depressive symptoms
patient reported